---
title: "HIMS stock has quadrupled in 5 years: How Hims turned a $3 stock into a telehealth giant"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296173657.md"
description: "Hims & Hers Health (HIMS) celebrated its fifth anniversary as a public company, with stock up 314% since its 2021 SPAC debut. Revenue surged from $272 million in 2021 to $2.3 billion in 2025, driven by weight-loss demand and international expansion. The company shifted strategy after a Novo Nordisk partnership dispute, now offering branded GLP-1 drugs while leveraging AI to reduce support costs. Despite trading below its February 2025 peak, Hims continues global growth with nearly 3 million subscribers."
datetime: "2026-08-18T03:54:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296173657.md)
  - [en](https://longbridge.com/en/news/296173657.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296173657.md)
generator: "portal-rs"
---

# HIMS stock has quadrupled in 5 years: How Hims turned a $3 stock into a telehealth giant

・HIMS stock has gained 314% over five years as the former SPAC evolved into a global healthcare platform. ・Annual revenue surged from $272 million in 2021 to $2.3 billion in 2025, representing a compound annual growth rate of nearly 64%. ・Hims’ AI-native care platform tripled customer messaging and reduced nonclinical support work by nearly 50%. Hi...

### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md)
- [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [HIYY.US](https://longbridge.com/en/quote/HIYY.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)

## Related News & Research

- [J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?](https://longbridge.com/en/news/298771060.md)
- [13:50 ETHims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS](https://longbridge.com/en/news/298229527.md)
- [Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 Deadline](https://longbridge.com/en/news/298506559.md)
- [JPMorgan Tweaks Hims & Hers Stock Outlook on Key Risk](https://longbridge.com/en/news/298770772.md)
- [Is FTC Lawsuit Altering The Investment Case For Hims Stock (HIMS)?](https://longbridge.com/en/news/298457831.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**